Serial Number 77112202
Registration 3633348
800

Registration Progress

Application Filed
Feb 21, 2007
Under Examination
Approved for Publication
Published for Opposition
Registered
Jun 2, 2009

Trademark Image

Basic Information

Serial Number
77112202
Registration Number
3633348
Filing Date
February 21, 2007
Registration Date
June 2, 2009
Renewal Date
June 2, 2019
Drawing Code
2

Status Summary

Current Status
Active
Status Code
800
Status Date
Apr 27, 2020
Registration
Registered
Classes
005

Rights Holder

RB HEALTH (US) LLC

16
Address
399 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Ownership History

Adams Respiratory Operations, Inc.

Original Applicant
03
Fort Worth, TX

RECKITT BENCKISER, INC.

New Owner Before Publication #1
03
PARSIPPANY, NJ

RECKITT BENCKISER, INC.

Original Registrant
03
PARSIPPANY, NJ

RECKITT BENCKISER LLC

New Owner After Registration #1
16
PARSIPPANY, NJ

RB HEALTH (US) LLC

New Owner After Registration #2
16
PARSIPPANY, NJ

Legal Representation

Attorney
Mark Lerner Esq.

USPTO Deadlines

Next Deadline
1421 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2009-06-02)
Due Date
June 02, 2029
Grace Period Ends
December 02, 2029

Application History

47 events
Date Code Type Description
Apr 27, 2020 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Apr 27, 2020 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Apr 27, 2020 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Feb 26, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 26, 2019 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jun 8, 2019 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Jun 7, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 2, 2019 E89R I TEAS SECTION 8 & 9 RECEIVED
Nov 21, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 2, 2018 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 19, 2015 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 19, 2015 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 24, 2014 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Oct 24, 2014 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED
Oct 23, 2014 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 16, 2014 ES8R I TEAS SECTION 8 RECEIVED
Oct 16, 2014 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 2, 2011 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 2, 2009 R.SR A REGISTERED-SUPPLEMENTAL REGISTER
Apr 27, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 23, 2009 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Apr 6, 2009 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 3, 2009 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 23, 2009 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 24, 2008 GNS1 O NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Oct 24, 2008 GNSF O SUBSEQUENT FINAL EMAILED
Oct 24, 2008 CFRC R SUBSEQUENT FINAL REFUSAL WRITTEN
Sep 13, 2008 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 13, 2008 GNFR O FINAL REFUSAL E-MAILED
Sep 13, 2008 CNFR R FINAL REFUSAL WRITTEN
Aug 7, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 16, 2008 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 7, 2008 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 7, 2008 GNRT O NON-FINAL ACTION E-MAILED
Feb 7, 2008 CNRT R NON-FINAL ACTION WRITTEN
Jan 3, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 3, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 3, 2008 ALIE A ASSIGNED TO LIE
Nov 20, 2007 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2007 GNRT F NON-FINAL ACTION E-MAILED
May 21, 2007 CNRT R NON-FINAL ACTION WRITTEN
May 16, 2007 DOCK D ASSIGNED TO EXAMINER
Feb 27, 2007 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED
Feb 26, 2007 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
First Use Anywhere: Oct 1, 2005
First Use in Commerce: Oct 1, 2005

Additional Information

Design Mark
The mark consists of the colors orange and white as applied to the bi-layer guaifenensin and pseudoephedrine extended-release tablets with orange on top for extended release and white on bottom indicating immediate release, the broken lines only serve to show the positioning of the mark on the product and that the shape of the product is not claimed as part of the mark.
Color Claim
The color(s) Orange and White is/are claimed as a feature of the mark.

Classification

International Classes
005